Andrew D Wisneski
Overview
Explore the profile of Andrew D Wisneski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moaven O, Mainali B, Valenzuela C, Russell G, Cheung T, Corvera C, et al.
J Surg Oncol
. 2024 Aug;
130(8):1654-1661.
PMID: 39183490
Background: This study investigates the impact of margin status after colorectal liver metastasis (CLM) resection on outcomes of patients after neoadjuvant treatment versus those who underwent upfront resection. Methods: An...
2.
Mainali B, Valenzuela C, Moaven O, Stauffer J, Del Piccolo N, Cheung T, et al.
J Surg Oncol
. 2024 Aug;
130(3):516-522.
PMID: 39099202
Background: Thermal ablation has recently become a key therapy for the treatment of colorectal liver metastasis (CLM). However, the role of ablation in combination with resection has not yet been...
3.
Wong P, Wisneski A, Tsai K, Chang T, Hirose K, Nakakura E, et al.
World J Surg Oncol
. 2024 Mar;
22(1):77.
PMID: 38468341
Background: Metastatic melanoma to the small bowel is an aggressive disease often accompanied by obstruction, abdominal pain, and gastrointestinal bleeding. With advancements in melanoma treatment, the role for metastasectomy continues...
4.
Wong P, Wisneski A, Sandhu A, Wang Z, Mahadevan V, Nguyen T, et al.
Front Cardiovasc Med
. 2023 May;
10:1140379.
PMID: 37168656
Severe mitral valve regurgitation (MR) is a heart valve disease that progresses to end-stage congestive heart failure and death if left untreated. Surgical repair or replacement of the mitral valve...
5.
Wisneski A, Hamilton B, Nguyen T
JTCVS Tech
. 2023 Apr;
18:44-50.
PMID: 37096098
Objective: Mitral valve disease in presence of severe mitral annular calcification (MAC) remains a challenge for surgeons to address. Conventional surgical techniques have potential for heightened morbidity and mortality. The...
6.
Valenzuela C, Moaven O, Solsky I, Stauffer J, Del Piccolo N, Cheung T, et al.
Ann Surg Oncol
. 2023 Mar;
30(6):3413-3422.
PMID: 36859704
Introduction: Complete resection of colorectal liver metastasis (CLM) improves long-term survival in colorectal cancer. However, there is limited recent data on conditional survival (CS) as postoperative survival milestones are achieved...
7.
Solsky I, Moaven O, Valenzuela C, Lundy M, Stauffer J, Del Piccolo N, et al.
Ann Surg Oncol
. 2023 Feb;
30(7):4264-4273.
PMID: 36754944
Background: Although colorectal hepatic metastases (HM) and peritoneal surface disease (PSD) are distinct biologic diseases, they may have similar long-term survival when optimally treated with surgery. Methods: This study retrospectively...
8.
Valenzuela C, Moaven O, Gawdi R, Stauffer J, Del Piccolo N, Cheung T, et al.
J Surg Oncol
. 2022 Aug;
126(7):1242-1252.
PMID: 35969175
Background: Resection of colorectal liver metastasis (CLM) is beneficial when feasible. However, the benefit of second hepatectomy for hepatic recurrence in CLM remains unclear. Methods: The Colorectal Liver Operative Metastasis...
9.
Wisneski A, Wang Y, Cutugno S, Pasta S, Stroh A, Yao J, et al.
Front Physiol
. 2022 Apr;
13:848011.
PMID: 35464089
This study aimed to create an imaging-derived patient-specific computational model of low-flow, low-gradient (LFLG) aortic stenosis (AS) to obtain biomechanics data about the left ventricle. LFLG AS is now a...
10.
Gawdi R, Valenzuela C, Moaven O, Stauffer J, Del Piccolo N, Cheung T, et al.
J Surg Oncol
. 2022 Apr;
126(2):339-347.
PMID: 35429409
Background: Chemotherapy has been increasingly combined with surgery as multimodality treatment for resectable colorectal-liver metastases (CLM). There is paucity of clinical data addressing optimal timing of chemotherapy relative to surgery....